东诚药业：累计公司股份4028699股

Core Viewpoint - Dongcheng Pharmaceutical (002675) announced a share buyback plan, indicating a commitment to enhancing shareholder value through the repurchase of its own shares [1] Group 1: Share Buyback Details - As of January 31, 2026, the company has repurchased a total of 4,028,699 shares [1] - The repurchased shares represent 0.49% of the company's total share capital [1]